Edesa Biotech Ownership | Who Owns Edesa Biotech?

Edesa Biotech Ownership Summary

Edesa Biotech is owned by 40.96% institutional investors, 28.82% insiders, and 30.22% retail investors. Stonepine capital management is the largest institutional shareholder, holding 9.79% of EDSA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.46% of its assets in Edesa Biotech shares.

EDSA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Edesa Biotech	40.96%	28.82%	30.22%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Stonepine capital management	687.50K	9.79%	$1.70M
Rubric capital management lp	687.50K	9.79%	$1.70M
Velan capital investment management lp	687.50K	9.79%	$1.70M
Nantahala capital management	625.00K	8.90%	$1.54M
Vanguard group	45.54K	0.65%	$111.13K
Geode capital management	45.23K	0.64%	$110.38K
Commonwealth equity services	37.55K	0.53%	$93.00K
Renaissance	25.00K	0.36%	$61.75K
Citigroup	2.00K	0.03%	$4.88K
Royal bank of canada	1.82K	0.03%	$4.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Velan capital investment management lp	687.50K	1.59%	$1.70M
Stonepine capital management	687.50K	1.38%	$1.70M
Nantahala capital management	625.00K	0.05%	$1.54M
Rubric capital management lp	687.50K	0.02%	$1.70M
Commonwealth equity services	37.55K	0.00%	$93.00K
Renaissance	25.00K	0.00%	$61.75K
Tower research capital llc (trc)	1.28K	0.00%	$3.16K
Td waterhouse canada	142.00	-	$362.00
Fifth third bancorp	100.00	-	$247.00
Barclays	6.00	-	$14.00

Top Buyers

Holder	Shares	% Assets	Change
Stonepine capital management	687.50K	1.38%	687.50K
Vanguard group	45.54K	-	29.68K
Renaissance	25.00K	0.00%	25.00K
Geode capital management	45.23K	-	17.28K
Commonwealth equity services	37.55K	0.00%	2.54K

Top Sellers

Holder	Shares	% Assets	Change
Cibc world market	-	-	-20.00K
Tower research capital llc (trc)	1.28K	0.00%	-1.06K
Morgan stanley	-	-	-584.00
Raymond james financial	-	-	-29.00
Td waterhouse canada	142.00	-	-

New Positions

Holder	Shares	% Assets	Change	Value
Renaissance	25.00K	0.00%	25.00K	$61.75K
Citigroup	2.00K	-	2.00K	$4.88K
Barclays	6.00	-	6.00	$14.00
Danske bank	1.00	-	1.00	$2.00

Sold Out

Holder	Change
Raymond james financial	-29.00
Morgan stanley	-584.00
Cibc world market	-20.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	22	15.79%	2,876,708	36.46%	40	2.59%	10	25.00%	3	50.00%
Jun 30, 2025	19	5.56%	2,108,116	-25.30%	39	1.40%	8	-	2	-33.33%
Mar 31, 2025	18	12.50%	2,822,206	1260.01%	53	138.22%	8	33.33%	3	50.00%
Dec 31, 2024	16	-5.88%	207,513	28.61%	6	24.36%	6	50.00%	2	100.00%
Sep 30, 2024	17	-	161,348	7.05%	5	23.06%	4	-20.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	32.27K	0.46%	16.56K
Fidelity Extended Market Index	16.89K	0.24%	503.00
DFA US Micro Cap I	7.91K	0.11%	-
DFA US Core Equity 2 I	3.42K	0.10%	-
Spartan Extended Market Index Pool F	4.67K	0.07%	119.00
Spartan Extended Market Index Pool E	4.39K	0.06%	4.17K
Fidelity Series Total Market Index	4.16K	0.06%	-
NT Ext Equity Mkt Idx Fd - L	1.93K	0.03%	-
Northern Trust Extended Eq Market Idx	1.93K	0.03%	-
Fidelity Nasdaq Composite Index	1.33K	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 25, 2024	Nijhawan Pardeep	Chief Executive Officer	Buy	$20.00K
Jan 10, 2023	van der Velden Peter	-	Sell	$367.39K
Jan 09, 2023	van der Velden Peter	-	Sell	$32.70K
Jan 10, 2023	van der Velden Peter	-	Sell	$33.97K
Jan 09, 2023	van der Velden Peter	-	Sell	$353.65K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

EDSA Ownership FAQ

Who Owns Edesa Biotech?

Edesa Biotech shareholders are primarily institutional investors at 40.96%, followed by 28.82% insiders and 30.22% retail investors. The average institutional ownership in Edesa Biotech's industry, Biotech Stocks , is 45.24%, which Edesa Biotech falls below.

Who owns the most shares of Edesa Biotech?

Edesa Biotech’s largest shareholders are Stonepine capital management (687.5K shares, 9.79%), Rubric capital management lp (687.5K shares, 9.79%), and Velan capital investment management lp (687.5K shares, 9.79%). Together, they hold 29.37% of Edesa Biotech’s total shares outstanding.

Does Blackrock own Edesa Biotech?

BlackRock is not among the top 10 institutional shareholders of Edesa Biotech.

Who is Edesa Biotech’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Edesa Biotech’s biggest shareholder by percentage of total assets invested, with 1.59% of its assets in 687.5K Edesa Biotech shares, valued at 1.7M$.

Who is the top mutual fund holder of Edesa Biotech shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Edesa Biotech shares, with 0.46% of its total shares outstanding invested in 32.26K Edesa Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools